Home
>
US Stocks
>
Sio Gene Therapies Inc
Sio Gene Therapies Inc
SIOX

Sio Gene Therapies Inc

$2.2712.38%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
2.24
Today Low/High
2.18 / 2.32
52 Week Low/High
$1.86 / $5.74
Market Cap
$138.59M

Company Details

Sio Gene Therapies combines cutting-edge science with bold imagination to develop genetic medicines that aim to radically improve the lives of patients. Its current pipeline of clinical-stage candidates includes the first potentially curative AAV-based gene therapies for GM1 gangliosidosis and Tay-Sachs/Sandhoff diseases, which are rare and uniformly fatal pediatric conditions caused by single gene deficiencies. The company is also expanding the reach of gene therapy to highly prevalent conditions such as Parkinson's disease, which affects millions of patients globally. Led by an experienced team of gene therapy development experts, and supported by collaborations with premier academic, industry and patient advocacy organizations, Sio is focused on accelerating its candidates through clinical trials to liberate patients with debilitating diseases through the transformational power of gene therapies.
Organisation
Sio Gene Therapies Inc
Headquaters
11 12 St Jamess Square, London, United Kingdom
Employees
38
Industry
Health Technology
CEO
Pavan Cheruvu

Discover more

Frequently Asked Questions

What is Sio Gene Therapies Inc share price today

Can Indians buy Sio Gene Therapies Inc shares?

How can I buy Sio Gene Therapies Inc shares from India?

Can Fractional shares of Sio Gene Therapies Inc be purchased?

What are the documents required to start investing in Sio Gene Therapies Inc stocks?

We are a SEBI registered investement advisor